PHA-794428

DRUG2 trials

Sponsors

Pfizer

Conditions

Growth Hormone Deficiency

Phase 2

A Study To Evaluate The Dose Response And Safety Of PHA-794428 In Adults With Growth Hormone Deficiency

TerminatedNCT00308464

PfizerGrowth Hormone Deficiency

Start: 2006-07-31End: 2007-12-31Target: 136Updated: 2011-05-18

A Single Dose Study to Evaluate the PK-PD Response and Safety of PHA-794428 in Children With Growth Hormone Deficiency

TerminatedNCT00314938

PfizerGrowth Hormone Deficiency

Start: 2006-04-30End: 2007-11-30Target: 32Updated: 2011-05-16